Table 2.
Baseline characteristics of patients hospitalized in the COVID-Like Disease (CLD) cohort and the COVID-19 cohort.
| Variables | CLD | COVID-19 |
p-value* | |||
|---|---|---|---|---|---|---|
| SHA | Intermountain | Total | ||||
| Total, N | 14,030 | 185 | 259 | 444 | ||
| Age (years), Mean ± SD | 63.7 ± 18.9 | 53.9 ± 17.8 | 53.0 ± 16.5 | 53.4 ± 17.2 | <0.001 | |
| Gender | Male | 7673 (54.7) | 92 (49.7) | 145 (56.0) | 237 (53.4) | 0.582 |
| Race, N (%) | White | 7990 (56.9) | 42 (22.7) | 179 (69.1) | 221 (49.8) | <0.001 |
| Asian | 2213 (15.8) | 24 (13.0) | <10 | 26 (5.9) | ||
| Black | 867 (6.2) | <10 | <10 | 15 (3.4) | ||
| Other | 2612 (18.6) | 97 (52.4) | 72 (27.8) | 169 (38.1) | ||
| Ethnicity | Hispanic | 2023 (14.4) | 94 (50.8) | 98 (37.8) | 192 (43.2) | <0.001 |
| Insurance, N(%) | Private | 3309 (23.6) | 38 (20.5) | 123 (47.5) | 161 (36.3) | < 0.001 |
| Public | 8976 (63.9) | 130 (70.2) | 121 (46.7) | 251 (56.5) | ||
| Other | 333 (2.4) | 17 (9.2) | 14 (5.4) | 31 (7.0) | ||
| Ever smoke, N (%) | 5675 (40.4) | 55 (29.7) | 40 (15.4) | 95 (21.4) | < 0.001 | |
| One or more comorbidity, N(%) | 9108 (64.9) | 64 (34.6) | 148 (57.1) | 212 (47.7) | <0.001 | |
| IMV, N (%) | 3775 (26.9) | 25 (13.5) | 35 (13.5) | 60 (13.5) | <0.001 | |
| Time to IMV (days), Mean ± SD | 4.1 ± 7.6 | 3.2 ± 4.3 | 2.7 ± 2.2 | 2.9 ± 3.2 | 0.001 | |
| Inpatient mortality, N (%) | 1925 (13.7) | <10† | 11 (4.3) | – | <0.001 | |
Note. *p value was calculated comparing patients with CLDs to the COVID-19 combined cohort; Percentages may not add up to 100 due to missing values.